Microbot Medical Inc (MBOT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Microbot Medical Inc (MBOT) has a cash flow conversion efficiency ratio of -0.068x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.05 Million) by net assets ($74.11 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Microbot Medical Inc to measure how much of total assets are equity-financed.
Microbot Medical Inc - Cash Flow Conversion Efficiency Trend (1991–2025)
This chart illustrates how Microbot Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Microbot Medical Inc (MBOT) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Microbot Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Microbot Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GCL NEW ENERGY HD-0832
F:TJI
|
N/A |
|
John Hancock Investors Closed Fund
NYSE:JHI
|
0.068x |
|
Shree Digvijay Cement Co.Ltd
NSE:SHREDIGCEM
|
-0.145x |
|
Hurco Companies Inc
NASDAQ:HURC
|
0.019x |
|
Europap Tezol Kagit Sanayi Ve Ticaret AS
IS:TEZOL
|
0.105x |
|
DaeChang Solution Co. Ltd
KQ:096350
|
-0.002x |
|
Luxchem Corporation Bhd
KLSE:5143
|
0.003x |
|
Southern Hydropower JSC
VN:SHP
|
0.102x |
Annual Cash Flow Conversion Efficiency for Microbot Medical Inc (1991–2025)
The table below shows the annual cash flow conversion efficiency of Microbot Medical Inc from 1991 to 2025. For the full company profile with market capitalisation and key ratios, see Microbot Medical Inc market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $77.55 Million | $-13.05 Million | -0.168x | +93.27% |
| 2024-12-31 | $3.53 Million | $-8.83 Million | -2.501x | -31.90% |
| 2023-12-31 | $4.50 Million | $-8.53 Million | -1.896x | -19.65% |
| 2022-12-31 | $7.29 Million | $-11.55 Million | -1.584x | -143.59% |
| 2021-12-31 | $14.38 Million | $-9.35 Million | -0.650x | -118.02% |
| 2020-12-31 | $24.31 Million | $-7.25 Million | -0.298x | -45.86% |
| 2019-12-31 | $31.54 Million | $-6.45 Million | -0.205x | +94.88% |
| 2018-12-31 | $1.33 Million | $-5.31 Million | -3.992x | -719.22% |
| 2017-12-31 | $9.96 Million | $-4.86 Million | -0.487x | -5.16% |
| 2016-12-31 | $1.70 Million | $-786.00K | -0.463x | -120.23% |
| 2015-12-31 | $-334.00K | $-765.00K | 2.290x | +149.16% |
| 2014-12-31 | $5.87 Million | $-27.35 Million | -4.659x | -198.73% |
| 2013-12-31 | $14.95 Million | $-23.32 Million | -1.560x | -9.77% |
| 2012-12-31 | $13.98 Million | $-19.87 Million | -1.421x | +30.92% |
| 2011-12-31 | $10.73 Million | $-22.06 Million | -2.057x | -29.85% |
| 2010-12-31 | $15.48 Million | $-24.52 Million | -1.584x | -95.69% |
| 2009-12-31 | $30.50 Million | $-24.68 Million | -0.809x | +22.38% |
| 2008-12-31 | $21.81 Million | $-22.74 Million | -1.043x | -76.04% |
| 2007-12-31 | $35.21 Million | $-20.86 Million | -0.592x | -100.00% |
| 2006-12-31 | $54.38 Million | $-16.10 Million | -0.296x | +19.23% |
| 2005-12-31 | $32.38 Million | $-11.87 Million | -0.367x | -20.17% |
| 2004-12-31 | $36.95 Million | $-11.27 Million | -0.305x | +60.84% |
| 2003-12-31 | $10.96 Million | $-8.54 Million | -0.779x | +70.74% |
| 2002-12-31 | $3.79 Million | $-10.09 Million | -2.663x | -234.50% |
| 2001-12-31 | $13.21 Million | $-10.52 Million | -0.796x | -189.61% |
| 2000-12-31 | $22.98 Million | $-6.32 Million | -0.275x | +92.28% |
| 1999-12-31 | $3.51 Million | $-12.49 Million | -3.562x | -593.02% |
| 1998-12-31 | $17.90 Million | $-9.20 Million | -0.514x | -7.64% |
| 1997-12-31 | $28.90 Million | $-13.80 Million | -0.478x | -65.70% |
| 1996-12-31 | $34.70 Million | $-10.00 Million | -0.288x | -227.09% |
| 1995-12-31 | $45.40 Million | $-4.00 Million | -0.088x | +85.14% |
| 1994-12-31 | $22.60 Million | $-13.40 Million | -0.593x | -71.90% |
| 1993-12-31 | $34.50 Million | $-11.90 Million | -0.345x | -13.17% |
| 1992-12-31 | $29.20 Million | $-8.90 Million | -0.305x | +10.95% |
| 1991-12-31 | $14.90 Million | $-5.10 Million | -0.342x | -- |
About Microbot Medical Inc
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, periph… Read more